RecruitingAsthma
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Eligible age
4–11 yrs
Accepts
All genders
Locations
8 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to evaluate the effect of 2 different GP metered dose inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma.
Sponsor: AstraZeneca
Where it's recruiting
California
Bakersfield · Long Beach · San Diego
Florida
Miami · Pembroke Pines
Kentucky
Owensboro
Louisiana
Lafayette
Massachusetts
Boston
Missouri
Columbia
Ohio
Cincinnati
Oklahoma
Oklahoma City
Source: ClinicalTrials.gov · NCT07525375 · last updated 2026-04-22